Table A1.
Receptors and ion channels with no binding affinity for W-212393 (IC50>1000 nM)
| Adenosin A1 (human) | Opioid κ (human) |
| Adrenergic α1, nonselective (human) | Opioid δ (human) |
| Adrenergic α2, nonselective (human) | Serotonin 5-HT1A (rat) |
| Adrenergic β1 (human) | Serotonin 5-HT2 (human) |
| Adrenergic β2 (human) | Serotonin 5-HT3 (human) |
| Adrenergic β3 (human) | Serotonin 5-HT4 (guinea-pig) |
| Bradykinin B2 (human) | Serotonin 5-HT5A (human) |
| Dopamine D1 (human) | Serotonin 5-HT6 (human) |
| Dopamine D2 (human) | Serotonin 5-HT7 (human) |
| Dopamine D3 (human) | Sigma, nonselective (guinea-pig) |
| Dopamine D4.4 (human) | Somatostatin sst1 (human) |
| Dopamine D5 (human) | Dopamine transporter (human) |
| GABAA, agonist site (rat) | Norepinephrine transporter (human) |
| GABAA, benzodiazepine, central (rat) | |
| GABAB, nonselective (rat) | Calcium channel, L-type (rat) |
| Glucocorticoid (human) | Calcium channel, N-type (rat) |
| Glutamate, nonselective (rat) | Sodium channel, Site 1 (rat) |
| Histamine H1 (human) | Potassium channel [KATP] (hamster) |
| Melatonin ML (MT), nonselective (chicken) | Potassium channel [SKCa] (rat) |
| Muscarinic, nonselective, Central (rat) | |
| Neuropeptide Y1 (human) | |
| Nicotinic acetylcholine (human) |